Market Closed -
Other stock markets
|
After market 09:04:06 am | |||
197.35 USD | +0.56% |
|
197.46 | +0.06% |
15/02 | Tranche Update on AbbVie Inc.'s Equity Buyback Plan announced on February 15, 2018. | CI |
15/02 | Correction to AbbVie Names CEO Robert Michael Chairman Article | DJ |
Capitalization | 346B 333B 313B 276B 493B 30,109B 546B 3,726B 1,391B 12,575B 1,299B 1,273B 52,530B | P/E ratio 2025 * |
26.4x | P/E ratio 2026 * | 21.8x |
---|---|---|---|---|---|
Enterprise value | 399B 383B 361B 317B 567B 34,668B 629B 4,290B 1,601B 14,479B 1,496B 1,465B 60,483B | EV / Sales 2025 * |
6.72x | EV / Sales 2026 * | 6.08x |
Free-Float |
96.39% | Yield 2025 * |
3.32% | Yield 2026 * | 3.47% |
Last Transcript: AbbVie Inc.
1 day | +0.62% | ||
1 week | +2.88% | ||
Current month | +7.31% | ||
1 month | +15.03% | ||
3 months | +18.69% | ||
6 months | +1.78% | ||
Current year | +11.06% |







Manager | Title | Age | Since |
---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 54 | 01/07/2024 |
Scott Reents
DFI | Director of Finance/CFO | 58 | 23/06/2022 |
Roopal Thakkar
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2003 |
Director | Title | Age | Since |
---|---|---|---|
Richard Gonzalez
CHM | Chairman | 71 | 01/01/2013 |
Roxanne Austin
BRD | Director/Board Member | 64 | 01/01/2013 |
William Burnside
BRD | Director/Board Member | 73 | 01/01/2013 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.12% | 6 M€ | 0.00% | - | |
6.85% | 33 M€ | +3.72% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.56% | +2.88% | +11.19% | +37.02% | 346B | ||
+1.15% | +0.24% | +10.87% | +260.80% | 772B | ||
+1.87% | +1.13% | +0.86% | -3.35% | 373B | ||
+1.79% | -0.45% | -29.78% | +80.57% | 366B | ||
-0.07% | +2.26% | +29.14% | -13.97% | 263B | ||
-0.71% | +0.69% | +15.95% | +32.98% | 231B | ||
+2.77% | -1.09% | -33.02% | +12.09% | 211B | ||
+0.44% | -1.48% | +9.22% | +20.99% | 211B | ||
+0.50% | -0.81% | +3.73% | +33.29% | 157B | ||
+1.29% | +1.41% | -6.26% | -46.65% | 145B | ||
Average | +0.87% | -0.47% | +1.19% | +41.38% | 307.37B | |
Weighted average by Cap. | +0.96% | -0.46% | +2.50% | +81.89% |
2025 * | 2026 * | |
---|---|---|
Net sales | 59.35B 57.03B 53.71B 47.21B 84.43B 5,158B 93.58B 638B 238B 2,154B 223B 218B 8,999B | 63.95B 61.45B 57.87B 50.86B 90.96B 5,558B 101B 688B 257B 2,321B 240B 235B 9,696B |
Net income | 11.88B 11.42B 10.75B 9.45B 16.91B 1,033B 18.74B 128B 47.7B 431B 44.55B 43.65B 1,802B | 14.84B 14.26B 13.43B 11.8B 21.11B 1,290B 23.4B 160B 59.57B 539B 55.64B 54.51B 2,250B |
Net Debt | 52.46B 50.41B 47.47B 41.72B 74.62B 4,559B 82.71B 564B 211B 1,904B 197B 193B 7,954B | 42.53B 40.87B 38.49B 33.83B 60.5B 3,697B 67.06B 457B 171B 1,544B 159B 156B 6,449B |
Date | Price | Change | Volume |
---|---|---|---|
20/02/25 | 197.35 $ | +0.56% | 4,887,984 |
18/02/25 | 196.25 $ | +1.75% | 6,065,546 |
14/02/25 | 192.87 $ | -0.30% | 3,976,903 |
13/02/25 | 193.45 $ | +0.23% | 4,108,920 |
12/02/25 | 193.00 $ | +0.61% | 4,525,009 |
Delayed Quote Nyse, 20 February 2025 at 08:00 am AEDT
More quotes
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ABBV Stock

MarketScreener is also available in this country: United States.
Switch edition